Freeline Company

Freeline is a clinical biotechnology company that develops transformative adeno-associated virus-vector-mediated systemic gene therapies. They use a designed AAV vector and capsid along with novel promoters and transgenes to deliver a functional copy of a therapeutic gene into human liver cells to express a functional level of the missing or dysfunctional protein into the patientвАЩs bloodstream. Their development programs including clinical trials focus on developing products.

Headquarters: Stevenage, Herefordshire, United Kingdom
Funding Status: IPO
Estimated Revenue: $1M to $10M
Technology: Others
Founded Date: 2015
Industry: Gene Therapy